Dr. Nirav Niranjan Shah explains the data behind why autologous stem cell transplant should remain the standard of care for patients with relapsed chemo-sensitive DLBCL.
Nirav Niranjan Shah, MD
Advertisement
Articles by Nirav Niranjan Shah, MD
Advertisement
Latest Updated Articles
Autologous Stem Cell Transplant Should Remain Standard of Care for Certain DLBCL Patients, Expert SaysPublished: June 9th 2020 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer
2
Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer
3
Tecentriq Plus Chemo Shows Comparable Survival in Endometrial Cancer
4
Trodelvy in Metastatic Triple-Negative Breast Cancer Supported by Phase 3 Trial
5
